Expression of ACE and ACE2 in Patients with Hypertensive Nephrosclerosis

Publisher： Karger

E-ISSN： 1423-0143|34|3|141-149

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.34, Iss.3, 2011-02, pp. : 141-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Factors Associated with Hypertensive Nephrosclerosis

By  

Nephron, Vol. 82, Iss. 3, 1999-06 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

Effect of an α-Adrenergic Blocker, and ACE Inhibitor and Hydrochlorothiazide on Blood Pressure and on Renal Function in Type 2 Diabetic Patients with Hypertension and Albuminuria

By  

Nephron, Vol. 80, Iss. 2, 1998-09 ,pp. : 175-182

Karger

Access to resources Recommend Favorite

Gentamicin Reduces Serum ACE Activity in Patients with Normal Kidney Function

By  

American Journal of Nephrology, Vol. 22, Iss. 5-6, 2002-10 ,pp. : 487-490

Karger

Access to resources Recommend Favorite

Significant Suppressive Effect of Low-Dose Temocapril, an ACE Inhibitor with Biliary Excretion, on FGS Lesions in Hypertensive Rats

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 491-498

Karger

Access to resources Recommend Favorite

Renoprotective Effect of ACE Inhibitors

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 537-537

Karger

Access to resources Recommend Favorite